Jessie, it looks like we are in agreement on how PPHM has enough time to finish a Phase 3 trial under the loan terms.
How do you estimate that?
Assuming they draw the full $30M, the loan terms state that ther pay down the principal in 30 equal payements between 9/13 and 3/16. That means by 12/14 they would have aprox $10M of the loan left in the bank from the loan. By 9/15, nothing.
A P3 trial would start about a year from now, they are not ready to launch one now. As they state in the PR for the loan the process would be:
. P2 data
. Disussions with FDA on approval path
. P3 Design (and the loan PR talks about being ready to start that by 3/13).
From then they need to complete the design, get an FDA signoff, and initiate the actual trial.
And the trial itself? 2 years from initiation would be lightspeed.
The loan certainly does provide some breathing room now so they can go forward w/o being either under the gone or forced to dullute at terms they might not like. That is good.
But it is not enough to get P3 data.
Market Data 
Markets 
AI
